Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Tobacco Induced Diseases
Published in: Tobacco Induced Diseases 1/2014

Open Access 01-06-2014 | Meeting abstract

Maternal tobacco use during pregnancy and risk of congenital heart defects in offspring: a systematic review

Authors: Aspasia Tzani, Konstantinos P Economopoulos

Published in: Tobacco Induced Diseases | Special Issue 1/2014

Login to get access

Excerpt

Numerous human studies have investigated potential teratogenic effects of maternal smoking during pregnancy, with conflicting findings [1, 2]. One of the most common birth malformations is congenital heart defect (CHD) with a prevalence of around 1% of live births [3, 4]. More specifically, several studies indicate that maternal tobacco use is related with increased risk of CHD, whereas other studies do not find any association [5, 6]. The aim of this study is to systematically review the literature regarding the correlation between maternal smoking during pregnancy and the prevalence of CHDs in offspring. …
Literature
1.
Kallen K: Maternal smoking and congenital heart defects. Eur J Epidemiol. 1999, 15: 731-737. 10.1023/A:1007671631188.CrossRefPubMed
2.
Karatza AA, Giannakopoulos I, Dassios TG, Belavgenis G, Mantagos SP, Varvarigou AA: Periconceptional tobacco smoking and isolated congenital heart defects in the neonatal period. Int J Cardiol. 2011, 148: 295-299. 10.1016/j.ijcard.2009.11.008.CrossRefPubMed
3.
Yerushalmy J: Congenital heart disease and maternal smoking habits. Nature. 1973, 242: 262-263. 10.1038/242262a0.CrossRefPubMed
4.
Hackshaw A, Rodeck C, Boniface S: Maternal smoking in pregnancy and birth defects: a systematic review based on 173,687 malformed cases and 11.7 million controls. Hum Reprod Update. 2011, 17: 589-604. 10.1093/humupd/dmr022.PubMedCentralCrossRefPubMed
5.
Perspectives in pediatric cardiology. Epidemiology of congenital heart disease. The Baltimore-Washington Infant Study 1981–1989. Edited by: Ferencz C, Rubin JD, Loffredo CA, Magee CA. New York: Futura Pub, Mount Kisco, 4: 1993-last page.
6.
Kuciene R, Dulskiene V: Maternal socioeconomic and lifestyle factors during pregnancy and the risk of congenital heart defects. Medicina Kaunas. 2009, 45: 904-909.PubMed
7.
Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, Hobbs CA: National Birth Defects Prevention Study: Maternal smoking and congenital heart defects. Pediatrics. 2008, 121: e810-e816. 10.1542/peds.2007-1519.CrossRefPubMed
Metadata
Title
Maternal tobacco use during pregnancy and risk of congenital heart defects in offspring: a systematic review
Authors
Aspasia Tzani
Konstantinos P Economopoulos
Publication date
01-06-2014
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue Special Issue 1/2014
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-12-S1-A20

Other articles of this Special Issue 1/2014

Tobacco Induced Diseases 1/2014 Go to the issue

Meeting abstract

Chronic bronchitis in oil industry workers exposed to hydrocarbons: role of cigarette smoking and gender differences

Meeting abstract

Quality of life among Greek smokers and nonsmokers. A study in local community workers in Athens suburbia

Meeting abstract

Nicotinic augmentation of anti-inflammatory GSK3b signaling

Meeting abstract

Epidemiology of smoking among the employees of a medical university and strategies to decrease prevalence

Meeting abstract

The importance of early COPD diagnosis during a smoking cessation program

Meeting abstract

Screening for lung cancer with Low-Dose Computed Tomography: a systematic review of the evidence
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits